Christiane Cordes
Warschauer Str. 33
Berlin, BE 10243, Germany
Berlin, BE 10243, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Cabotegravir+rilpivirine long-acting every 2 months in a real-world setting: 24-month outcomes in people with HIV-1.
Journal: AIDS (London, England)
Published: October 02, 2025
Cabotegravir+rilpivirine long-acting every 2 months in a real-world setting: 24-month outcomes in people with HIV-1.
Journal: AIDS (London, England)
Published: October 02, 2025
A Prospective Incidence Study on Sexually Transmitted Infections and HIV in Men Who Have Sex With Men, With or Without Use of Pre-exposure Prophylaxis.
Journal: Open forum infectious diseases
Published: September 08, 2025
Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study.
Journal: The Lancet. Infectious diseases
Published: October 03, 2024
Pop-up Langmuir probe diagnostic in the water cooled divertor of Wendelstein 7-X.
Journal: The Review of scientific instruments
Published: November 23, 2023
Reinfection incidence and risk among people treated for recent hepatitis C virus infection.
Journal: AIDS (London, England)
Published: July 19, 2023
Sofosbuvir plus velpatasvir for 8 weeks in patients with acute hepatitis C: The HepNet acute HCV-V study.
Journal: JHEP reports : innovation in hepatology
Published: November 08, 2022
Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study).
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 07, 2022
HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: April 08, 2022
Switching to a NRTI-free 2 drug regimen (2DR) -a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes.
Journal: HIV research & clinical practice
Published: March 02, 2022
Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance.
Journal: AIDS research and therapy
Published: May 08, 2021
Health-related quality-of-life in people living with HIV after switching to dual therapy with ritonavir-boosted darunavir + dolutegravir: a DUALIS sub-study.
Journal: AIDS care
Published: April 26, 2021
Last Updated: 09/26/2026